RedHill Biopharma Ltd. (RDHL) Forms $6.96 Double Bottom; 3 Bullish Analysts Covering Gulf Keystone Petroleum Limited (LON:GKP)

May 18, 2018 - By Cheryll Laflamme

Gulf Keystone Petroleum Limited (LON:GKP) Logo

Among 4 analysts covering Gulf Keystone Petroleum (LON:GKP), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Gulf Keystone Petroleum had 37 analyst reports since September 1, 2015 according to SRatingsIntel. The company was maintained on Wednesday, April 11 by Peel Hunt. The rating was maintained by Cantor Fitzgerald with “Buy” on Tuesday, April 12. Canaccord Genuity maintained it with “Speculative Buy” rating and GBX 2.80 target in Thursday, September 8 report. Canaccord Genuity maintained the shares of GKP in report on Tuesday, September 1 with “Hold” rating. As per Tuesday, March 8, the company rating was maintained by Cantor Fitzgerald. The firm has “Buy” rating by Cantor Fitzgerald given on Friday, February 19. As per Monday, October 2, the company rating was maintained by Peel Hunt. The firm earned “Buy” rating on Monday, January 22 by Peel Hunt. As per Monday, November 30, the company rating was maintained by Cantor Fitzgerald. As per Friday, September 11, the company rating was downgraded by Canaccord Genuity. See Gulf Keystone Petroleum Limited (LON:GKP) latest ratings:

11/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 270.00 New Target: GBX 270.00 Maintain
22/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 270.00 New Target: GBX 270.00 Maintain
22/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 270.00 New Target: GBX 270.00 Maintain
08/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 252.00 New Target: GBX 270.00 Maintain

RedHill Biopharma Ltd. (RDHL) formed double bottom with $6.68 target or 4.00% below today’s $6.96 share price. RedHill Biopharma Ltd. (RDHL) has $153.74M valuation. The stock decreased 0.85% or $0.06 during the last trading session, reaching $6.96. About 64,338 shares traded. RedHill Biopharma Ltd. (NASDAQ:RDHL) has declined 50.83% since May 18, 2017 and is downtrending. It has underperformed by 62.38% the S&P500.

Among 8 analysts covering RedHill Biopharma (NASDAQ:RDHL), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. RedHill Biopharma has $3600 highest and $18 lowest target. $25’s average target is 259.20% above currents $6.96 stock price. RedHill Biopharma had 15 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by TH Capital with “Buy” on Wednesday, July 29. The firm has “Buy” rating given on Monday, July 31 by Roth Capital. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) has “Outperform” rating given on Friday, February 24 by FBR Capital. Northland Capital initiated the shares of RDHL in report on Tuesday, September 29 with “Buy” rating. The firm has “Buy” rating given on Tuesday, September 29 by Nomura. On Thursday, June 15 the stock rating was maintained by H.C. Wainwright with “Buy”. The firm has “Buy” rating by FBR Capital given on Thursday, June 15. Zacks upgraded RedHill Biopharma Ltd. (NASDAQ:RDHL) on Saturday, August 22 to “Sell” rating. The firm earned “Buy” rating on Wednesday, May 9 by H.C. Wainwright. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) has “Buy” rating given on Tuesday, November 14 by Roth Capital.

Analysts await RedHill Biopharma Ltd. (NASDAQ:RDHL) to report earnings on July, 24. They expect $-0.47 earnings per share, up 21.67% or $0.13 from last year’s $-0.6 per share. After $-0.50 actual earnings per share reported by RedHill Biopharma Ltd. for the previous quarter, Wall Street now forecasts -6.00% EPS growth.

Gulf Keystone Petroleum Limited engages in the exploration, evaluation, and production of gas and oil properties in the Kurdistan Region of Iraq, the Republic of Algeria, and the United Kingdom. The company has market cap of 497.94 million GBP. The companyÂ’s principal asset is Shaikan block that covers an area of 283 square kilometers located north-west of Erbil. It has a 35.61 P/E ratio. It also provides geological, geophysical, and engineering services.

RedHill Biopharma Ltd. (NASDAQ:RDHL) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: